AstraZeneca COVID vaccine is the same as Covishield which is used in India and several other countries.

The drug, made from a combination of two antibodies, failed its main goal to treat Covid-19 symptoms in exposed patients, AstraZeneca said ...

PHE said the preliminary findings were the first of its kind on the effectiveness of two doses of AstraZeneca in a real-world setting but c...

The vaccine - developed with Oxford University and considered a frontrunner in the global vaccine race - has been plagued by safety concern...

The has been communication of scientific results. November data from trials in the U.K. and Brazil generated confusion over efficacy. This ...

In a nationwide broadcast on Sunday evening, Health Minister Mkhize said that the roll-out will be put on hold until a committee of scienti...

Officials said both the Pfizer and the SII emergency use applications are being reviewed on an accelerated basis. But as the trials for Ser...

The British drugmaker has said its Covid-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose, bu...

AstraZeneca/Oxford said this week it would assess why its vaccine candidate generated better efficacy at a lower dose. The statement came a...

The first batch of 100 participants in the Indian trial of the vaccine developed by University of Oxford and AstraZeneca were inoculated on...

The Serum Institute of India said it would restart its trials once it had permission from the Drugs Controller General of India, Reuters re...

Pharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the...

The study had been previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it ...

"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and wil...

Last month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...

AstraZeneca Plc said it had paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unex...

AstraZeneca began its Phase 3 trial in the US in late August. The US trial was currently taking place at 62 sites across the country.